Diagnostic value of blood lipids testing in patients with high-normal and subclinical levels of TSH in prevention and treatment of dislipoproteinemia

Cover Page


The purpose of the study is to evaluate character of lipid profile changes in Novosibirsk populational sample of men and women (45–69 years) with subclinical and high-normal TSH levels. Current study was performed within the HAPIEE project “Determinants of cardiovascular diseases in Eastern Europe” of the Welcome Trust fond. Populational subsample of 280 subjects (125 men (44.6%) and 155 women (55.4%)) was analyzed. Received data showed that high-normal TSH levels within 1.71–4.05 mIU/l have been associated with higher levels of triglycerides, total cholesterol and LDL cholesterol, compared with low-normal TSH levels 0.17–0.47 mIU/l (р<0.05). Women with subclinical hypothyroidism had significantly higher average levels of total cholesterol and LDL cholesterol compared with women without thyroid disorders.

About the authors

Email: rootnii@online.nsk.su
doktor med. nauk, starshiy nauchnyy sotrudnik laboratorii kliniko-populyatsionnykh i profi- lakticheskikh issledovaniy terapevticheskikh i endokrinnykh zabolevaniy NII terapii SO RAMN


  1. Дунтас Л. Щитовидная железа и липиды: современные представления // Thyroid Internat. 2004. №1. С. 3–12.
  2. Подзолков А.В., Фадеев В.В. Гипотиреоз, субклинический гипотиреоз, высоконормальный уровень ТТГ // Клин. экспер. тиреодол. 2009. Т. 5. №2. С. 4–7.
  3. Свиридонова М.А., А.В. Ильин, Колесникова Г.С., Фадеев В.В. Возможные последствия сужения референсного интервала для уровня ТТГ // Клин. экспер. тиреодол. 2009. Т. 5. №2. С. 30–33.
  4. Сыч Ю. П., Фадеев В. В., Мельниченко Г. А. и др. Нарушения липидного обмена при субклиническом гипотиреозе // Пробл. эндокринол. 2004. Т. 50. №3. С. 48–52.
  5. Фадеев В.В., Мельниченко Г.А. Гипотиреоз: Руководство для врачей. М.: РКИ Северо пресс, 2004.
  6. Althaus B.U., Staub J.J., Ryff-De Leche A. et al. LDL/HDL-changes in subclinical hypothyroidism: possible risk factors for coronary artery disease // CIin. Endocrinol. 1988. V. 28. P. 157–163.
  7. Baloch Z., Carayon P., Conte-Devolx B. et al. Guide-lines Committee, National Academy of Clinical Biochemistry. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease // Thyroid. 2003. V. 13. P. 3–126.
  8. Bland M. An introduction tu medical statistics. 3nd ed. Oxford: Oxford University Press, 2005.
  9. Caraccio N., Ferrannini E., Monzani F. Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study // J. Clin. Endocrinol. Metab. 2002. V. 87. P. 1533–1538.
  10. Caron P., Calazel N.,. Parra H.J et al. Decreased HDL cholesterol in subclinikal hypothyroidism: the effect of L-thyroxine therapy // J. Clin. Endocrinol. 1990. V. 33. P. 519–523.
  11. Fatourechi V., Klee G.G., Grebe S.K. et al. Effects of reducing the upper limit of normal TSH values // J.A.M.A. 2003. 290. Р. 3195–3196.
  12. Friedwald D.S., Levy R.J., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative centrifuge // Clin. Chem. 1972. V. 18. P. 499–502.
  13. Hamilton O.A., Davis S., Onstad L. et al. Thyrotropin levels in a population with no clinical, autoantibody, or ultrasonographic evidence of thyroid disease: implications for the diagnosis of subclinical hypothyroidism // J. Clin. Endocrinol. Metab. 2008. V. 93. N4. P. 1224–1230.
  14. Hollowell J.G., Staehling N.W., Flanders W.D. et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III) // J. Clin. Endocrinol. Metabol. 2002. V. 87. P. 489–499.
  15. Igbal A., Figenschau Y., Jorde R. Blood pressure in relation to serum thyrotropin: the Tromso study // J. Hum. Hypertens. 2006. V. 20. P. 932–936.
  16. Jensen E., Hyltoft-Petersen P., Blaabjerg O. et al. Establishment of a serum thyroid stimulating hormone (TSH) reference interval in healthy adults. The importance of environmental factors, including thyroid antibodies // Clin. Chem. Lab. Med. 2004. V. 42. N7. P. 824–832.
  17. Miller M.J., Pan C., Barzel U.S. The prevalence of subclinical hypothyroidism in adults with low-normal blood thyroxine levels // N.-Y. Stat. J. Med. 1990. V. 90. N11. P. 541–544.
  18. Park K.W., Dai H.B., Ojamaa K. et al. The direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance arteries // Anesth. Analg. 2002. V. 85. P. 734–738.
  19. Surks M.I., Goswami G., Daniels G.H. The thyrotropin reference range should remain unchanged // J. Clin. Endocrinol. Metab. 2005. V. 90. P. 5489–5496.
  20. Volzke H., Alte D., Kohlmann T. et al. Reference intervals of serum thyroid function tests in a previously iodine-deficient area // Thyroid. 2005. V. 15. N3. P. 279–285.



Abstract - 1188

PDF (Russian) - 746




Copyright (c) 2010 ., ., ., ., ., ., .

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies